date,title,source
Oct-17-18,Achaogen Submits Marketing Authorization Application to the European Medicines Agency for Plazomicin,GlobeNewswire
Oct-29-18,"Consolidated Research: 2018 Summary Expectations for Insys Therapeutics, Achaogen, Astec Industries, Central European Media Enterprises, Pzena Investment Management, and Clementia Pharmaceuticals  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Nov-05-18,"4 months after drug approval, Achaogen eyes fire sale",American City Business Journals
Nov-05-18,Achaogen Announces Review of Strategic Alternatives and Corporate Restructuring,GlobeNewswire
Nov-08-18,"Achaogen (AKAO) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-08-18,Achaogen: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Achaogen Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-09-18,Achaogen Announces Presentations at Two Investor Healthcare Conferences in November,GlobeNewswire
Nov-26-18,"Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics",American City Business Journals
Nov-26-18,Achaogen Announces Multiple Plazomicin Presentations at the American Society of Health Systems Pharmacists (ASHP) Midyear Clinical Meeting,GlobeNewswire
Dec-06-18,"Recent Analysis Shows Best Buy Co., News Corporation, Semtech, Achaogen, Infosys, and Galapagos NV Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Dec-10-18,Achaogen Announces FDA Clearance and Launch of the Thermo Scientific QMS Plazomicin Immunoassay,GlobeNewswire
Dec-11-18,Today's Research Reports on Trending Tickers: Achaogen and Arcadia Biosciences,ACCESSWIRE
Dec-21-18,"Could Achaogen, Inc.s (NASDAQ:AKAO) Investor Composition Influence The Stock Price?",Simply Wall St.
Feb-14-19,Achaogen Announces Proposed Public Offering of Common Stock,GlobeNewswire
Feb-14-19,Achaogen Submits Response to ASPR/BARDA Request for Information (RFI) for Antimicrobial Resistance Project BioShield,GlobeNewswire
Feb-14-19,Achaogen Provides Update on Corporate Progress and Key Preliminary Fourth Quarter 2018 Results,GlobeNewswire
Feb-15-19,Achaogen Announces Pricing of $15 Million Underwritten Public Offering,GlobeNewswire
Feb-20-19,Achaogen Announces Closing of $15 Million Underwritten Public Offering,GlobeNewswire
Feb-20-19,Achaogen Announces Presentations at Two Upcoming Investor Healthcare Conferences,GlobeNewswire
Feb-21-19,"Does Achaogen, Inc. (NASDAQ:AKAO) Have A High Beta?",Simply Wall St.
Mar-13-19,"Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2018 Financial Results on March 28, 2019",GlobeNewswire
Mar-28-19,Achaogen: 4Q Earnings Snapshot,Associated Press
Mar-28-19,Achaogen Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Mar-28-19,"The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO",Benzinga
Mar-29-19,Edited Transcript of AKAO earnings conference call or presentation 28-Mar-19 8:30pm GMT,Thomson Reuters StreetEvents
Apr-01-19,"Achaogen Inc (AKAO) Files 10-K for the Fiscal Year Ended on December 31, 2018",GuruFocus.com
Apr-04-19,Edited Transcript of AKAO earnings conference call or presentation 28-Mar-19 8:30pm GMT,Thomson Reuters StreetEvents
Apr-09-19,Achaogen (AKAO) Upgraded to Buy: Here's Why,Zacks
